IP Library Granted Patent US 9,145,578
Granted Patent B2
US 9,145,578 · App. 13/503,924 · Granted Sep 29, 2015

Method for assaying cholesterol in ApoE-containing HDL

Inventors: Yasuki Itoh (Niigata, JP); Hitoshi Chiba (Hokkaido, JP)
Assignees: Denka Seiken Co., Ltd.; National University Corporation Hokkaido University
C12Q1/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,145,578
App. No.
13/503,924
Granted
Sep 29, 2015
Kind
B2
Abstract

This invention provides a method for separately or simultaneously quantifying cholesterol in a total amount of HDL-C, cholesterol in an HDL subfraction of apoE-containing HDL-C, and cholesterol in an HDL subfraction of apoE-deficient HDL-C. The method comprises enzymatically and separately quantifying cholesterol in apoE-containing HDL and cholesterol in apoE-deficient HDL by adding a surfactant selected from the group consisting of a surfactant with an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 0.7 to less than 1.3, a surfactant with an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of less than 0.7, and a surfactant with an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 1.3 or more to a test sample, allowing cholesterol esterase and cholesterol oxidase to react therewith, and quantifying the hydrogen peroxide generated.

Claims (18)

1. A method of selectively and enzymatically quantifying cholesterol in apoE-deficient HDL by adding a surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of less than 0.7 to a test sample, allowing cholesterol esterase and cholesterol oxidase to react therewith, and quantifying the hydrogen peroxide generated, wherein the surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of less than 0.7 is selected from the group consisting of Polyoxyethylene nonylphenyl ether having an HLB of 16, Polyoxyethylene alkyl(coconut)amine having an HLB of 15.6, Polyoxyethylene stearylamine having an HLB of 15.4, Polyoxyethylene octyl phenyl ether having an HLB of 15, Polyoxyethylene stearylamine having an HLB of 12.8 and Polyoxyethylene beef tallow alkylamine having an HLB of 16.5.

2. A method of selectively and enzymatically quantifying cholesterol in apoE-containing HDL by adding a surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 1.3 or more to a test sample, allowing cholesterol esterase and cholesterol oxidase to react therewith, and quantifying the hydrogen peroxide generated, wherein the surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 1.3 or more is polyoxyethylene nonylphenyl ether having an HLB of 5 to 6.

3. A method of quantifying cholesterol in apoE-containing HDL comprising:

(a) selectively and enzymatically quantifying cholesterol in apoE-deficient HDL by adding a surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of less than 0.7 to a test sample, allowing cholesterol esterase and cholesterol oxidase to react therewith, and quantifying the hydrogen peroxide generated, wherein the surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of less than 0.7 is selected from the group consisting of Polyoxyethylene nonylphenyl ether having an HLB of 16, Polyoxyethylene alkyl(coconut)amine having an HLB of 15.6, Polyoxyethylene stearylamine having an HLB of 15.4, Polyoxyethylene octyl phenyl ether having an HLB of 15, Polyoxyethylene stearylamine having an HLB of 12.8 and Polyoxyethylene beef tallow alkylamine having an HLB of 16.5;

(b) enzymatically quantifying cholesterol in a total amount of HDL, including cholesterol in apoE-containing HDL, by adding a surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 0.7 to less than 1.3 to a test sample, allowing cholesterol esterase and cholesterol oxidase to react therewith, and quantifying the hydrogen peroxide generated, wherein the surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 0.7 to less than 1.3 is selected from the group consisting of 2-Ethylhexyl sulfate sodium salt, Polyoxyethylene alkyl ether having an HLB of 13.3, Polyoxyethylene laurylamine having an HLB of 6.2, Polyoxyethylene sorbitan monolaurate having an HLB of 16.7, Polyoxyethylene monooleate having an HLB of 13.7, Lauryl dimethyl aminoacetic acid betaine, Polyoxyethylene monolaurate having an HLB of 13.3, Polyoxyethylene sorbitan mono-coconut oil fatty acid ester having an HLB of 16.7, Polyoxyethylene alkyl ether having an HLB of 12, Polyoxyethylene monostearate having an HLB of 16.9, Polyoxyethylene alkyl ether having an HLB of 14, Polyoxyethylene sorbitan monostearate having an HLB of 14.9, Polyoxyethylene hydrogenated castor oil having an HLB of 12.5, Polyoxyethylene alkyl propylenediamine having an HLB of 6, and Sodium salt of lauryl sulfate; and

(c) subtracting the value of cholesterol in apoE-deficient HDL determined by step (a) from the value of total cholesterol including cholesterol-containing HDL and apoE-containing HDL determined by step (b) to determine the cholesterol level in apoE-containing HDL, wherein step (a) and step (b) can be carried out in any order.

4. The method of quantifying cholesterol in HDL according to claim 1 , which comprises a first step of erasing cholesterol in lipoproteins other than HDL in a test sample and a second step of quantifying cholesterol in HDL.

5. The method of quantifying cholesterol in HDL according to claim 2 , which comprises a first step of erasing cholesterol in lipoproteins other than HDL in a test sample and a second step of quantifying cholesterol in HDL.

6. The method of quantifying cholesterol in HDL according to claim 3 , which comprises a first step of erasing cholesterol in lipoproteins other than HDL in a test sample and a second step of quantifying cholesterol in HDL.

7. A method of quantifying cholesterol in apoE-containing HDL comprising: a first step of adding a surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio or less than 0.7 to a test sample, allowing the surfactant to selectively react with apoE-deficient HDL, and erasing or coagulating cholesterol in apoE-deficient HDL by way of the action of cholesterol esterase, cholesterol oxidase, and catalase; and a second step of adding a surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 0.7 to less than 1.3 or a surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 1.3 or more, and allowing the surfactant to react with remaining HDL in a test sample to quantify cholesterol in apoE-containing HDL,

wherein:

(a) the surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 0.7 to less than 1.3 is selected from the group consisting of 2-Ethylhexyl sulfate sodium salt, Polyoxyethylene alkyl ether having an HLB of 13.3, Lauryl alcohol alkoxylate, Polyoxyethylene laurylamine having an HLB of 6.2, Polyoxyethylene sorbitan monolaurate having an HLB of 16.7, Polyoxyethylene monooleate having an HLB of 13.7, Lauryl dimethyl aminoacetic acid betaine, Polyoxyethylene monolaurate having an HLB of 13.3, Polyoxyethylene sorbitan mono-coconut oil fatty acid ester having an HLB of 16.7, Polyoxyethylene alkyl ether having an HLB of 12, Polyoxyethylene monostearate having an HLB of 16.9, Polyoxyethylene alkyl ether having an HLB of 14, Polyoxyethylene sorbitan monostearate having an HLB of 14.9, Polyoxyethylene hydrogenated castor oil having an HLB of 12.5, Polyoxyethylene alkyl propylenediamine having an HLB of 6, and Sodium salt of lauryl sulfate; and

(b) the surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 1.3 or more is polyoxyethylene nonylphenyl ether having an HLB of 5 to 6.

8. A method of simultaneously quantifying cholesterol in apoE-containing HDL and cholesterol in total amount of HDL comprising: a first step of adding a surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of less than 0.7 to a test sample and generating hydrogen peroxide derived from cholesterol in apoE-deficient HDL; and a second step of detecting the hydrogen peroxide derived from cholesterol in apoE-deficient HDL at an early stage and simultaneously adding a surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 0.7 to less than 1.3 or a surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 1.3 or more and detecting the hydrogen peroxide derived from cholesterol in apoE-containing HDL,

wherein:

(a) the surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 0.7 to less than 1.3 is selected from the group consisting of 2-Ethylhexyl sulfate sodium salt, Polyoxyethylene alkyl ether having an HLB of 13.3, Polyoxyethylene laurylamine having an HLB of 6.2, Polyoxyethylene sorbitan monolaurate having an HLB of 16.7, Polyoxyethylene monooleate having an HLB of 13.7, Lauryl dimethyl aminoacetic acid betaine, Polyoxyethylene monolaurate having an HLB of 13.3, Polyoxyethylene sorbitan mono-coconut oil fatty acid ester having an HLB of 16.7, Polyoxyethylene alkyl ether having an HLB of 12, Polyoxyethylene monostearate having an HLB of 16.9, Polyoxyethylene alkyl ether having an HLB of 14, Polyoxyethylene sorbitan monostearate having an HLB of 14.9, Polyoxyethylene hydrogenated castor oil having an HLB of 12.5, Polyoxyethylene alkyl propylenediamine having an HLB of 6, and Sodium salt of lauryl sulfate;

(b) the surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of less than 0.7 is selected from the group consisting of Polyoxyethylene nonylphenyl ether having an HLB of 16, Polyoxyethylene alkyl(coconut)amine having an HLB of 15.6, Polyoxyethylene stearylamine having an HLB of 15.4, Polyoxyethylene octyl phenyl ether having an HLE of 15, Polyoxyethylene stearylamine having an HLB of 12.8 and Polyoxyethylene beef tallow alkylamine having an HLB of 16.5; and

(c) the surfactant having an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 1.3 or more is polyoxyethylene nonylphenyl ether having an HLB of 5 to 6.

Assignments (2)
MERGER Recorded Oct 5, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 053976/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2012
From: ITOH, YASUKI; CHIBA, HITOSHI
To: DENKA SEIKEN CO., LTD.; NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
Reel/Frame 028103/0734 →
Priority Claims (1)
JP 2009-245476 · Oct 26, 2009 · national
Continuity (1)
Related Publication 20120208219A1 · Aug 16, 2012